1st Quarter - Report

THE MCMANUS GROUP for GENENTECH

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Issues related to the Strategic National Stockpile.

Foreign entity interest: 100% ownership by F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, SUI

LobbyistCovered position, as disclosed
JOHN MCMANUS —
ALANNA TEMME —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Support for H.R.1304 - American Innovation and R&D Competitiveness Act of 2021.

Foreign entity interest: 100% ownership by F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, SUI

LobbyistCovered position, as disclosed
JOHN MCMANUS —
ALANNA TEMME —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1304 (117th)

Medicare/Medicaid MMM

Medicare Parts B and D reform. Access to Medicare Parts B and D in 340B Drug Pricing Program.

Foreign entity interest: 100% ownership by F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, SUI

LobbyistCovered position, as disclosed
JOHN MCMANUS —
ALANNA TEMME —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.